Funding for this research was provided by:
National Institutes of Health (1R01DK107416-01A1)
Dialysis Clinics Incorporated (NA)
Received: 19 November 2018
Accepted: 6 February 2019
First Online: 25 February 2019
Ethics approval and consent to participate
: Eligible participants in the HALT PKD trial were enrolled at seven clinical sites from February 2006 through June 2009. All the participants provided written informed consent.
: Not applicable.
: Partial funding was obtained from a grant from Dialysis Clinics Incorporated but DCI had no impact on the content of this article.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.